Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Pacific Biosciences of California Inc (NASDAQ: PACB) was $1.63 for the day, up 5.84% from the previous closing price of $1.54. In other words, the price has increased by $5.84 from its previous closing price. On the day, 12.96 million shares were traded.
Ratios:
Our analysis of PACB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 11.13 and its Current Ratio is at 12.63. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.32.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 18 ’25 when Farmer Michele sold 24,349 shares for $1.88 per share. The transaction valued at 45,727 led to the insider holds 187,592 shares of the business.
Van Oene Mark sold 100,773 shares of PACB for $189,252 on Feb 18 ’25. The insider now owns 1,496,681 shares after completing the transaction at $1.88 per share. On Feb 18 ’25, another insider, HENRY CHRISTIAN O, who serves as the insider of the company, sold 259,909 shares for $1.88 each. As a result, the insider received 488,109 and left with 2,237,854 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.90 while its Price-to-Book (P/B) ratio in mrq is 0.98.
Stock Price History:
Over the past 52 weeks, PACB has reached a high of $6.09, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is -8.25%, while the 200-Day Moving Average is calculated to be -8.41%.
Shares Statistics:
A total of 273.86M shares are outstanding, with a floating share count of 243.51M. Insiders hold about 11.08% of the company’s shares, while institutions hold 84.36% stake in the company.
